Characterization of the Radiolabeled Metabolites of [ 18 F]Altanserin: Implications for Kinetic Modeling
- 1 January 1998
- book chapter
- Published by Elsevier
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Radioligands for PET studies of central 5-HT receptors and re-uptake sites — Current statusNuclear Medicine and Biology, 1995
- Serotonin 5HT2 Receptor Imaging in the Human Brain Using Positron Emission Tomography and a New Radioligand, [18F]Altanserin: Results in Young Normal ControlsJournal of Cerebral Blood Flow & Metabolism, 1995
- Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brainLife Sciences, 1994
- Multicompartmental study of fluorine-18 altanserin binding to brain 5HT2 receptors in humans using positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Serotonin function and treatment response to clozapine in schizophrenic patientsAmerican Journal of Psychiatry, 1993
- Imaging the Serotonergic System by Positron Emission TomographyAnnals of the New York Academy of Sciences, 1990
- Pharmacokinetic approach to equilibrium between ketanserin and ketanserin-olEuropean Journal of Clinical Pharmacology, 1986
- Serotonin Receptor Changes in Dementia of the Alzheimer TypeJournal of Neurochemistry, 1984